Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Equity (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Return on Equity for 4 consecutive years, with 0.32% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Return on Equity rose 5.0% year-over-year to 0.32%, compared with a TTM value of 0.32% through Sep 2023, up 5.0%, and an annual FY2022 reading of 0.28%, up 207.0% over the prior year.
  • Return on Equity was 0.32% for Q3 2023 at Terns Pharmaceuticals, down from 0.26% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.35% in Q4 2020 and bottomed at 1.26% in Q1 2021.
  • Average Return on Equity over 4 years is 0.32%, with a median of 0.28% recorded in 2021.
  • The sharpest move saw Return on Equity plummeted -65bps in 2021, then skyrocketed 94bps in 2022.
  • Year by year, Return on Equity stood at 0.35% in 2020, then plummeted by -186bps to 0.3% in 2021, then increased by 13bps to 0.26% in 2022, then dropped by -22bps to 0.32% in 2023.
  • Business Quant data shows Return on Equity for TERN at 0.32% in Q3 2023, 0.26% in Q2 2023, and 0.24% in Q1 2023.